17-74769076-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004252.5(NHERF1):​c.*420C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.503 in 197,548 control chromosomes in the GnomAD database, including 25,323 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19384 hom., cov: 33)
Exomes 𝑓: 0.51 ( 5939 hom. )

Consequence

NHERF1
NM_004252.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.392

Publications

20 publications found
Variant links:
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
NHERF1 Gene-Disease associations (from GenCC):
  • hypophosphatemic nephrolithiasis/osteoporosis 2
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • dominant hypophosphatemia with nephrolithiasis or osteoporosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHERF1NM_004252.5 linkc.*420C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000262613.10 NP_004243.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHERF1ENST00000262613.10 linkc.*420C>T 3_prime_UTR_variant Exon 6 of 6 1 NM_004252.5 ENSP00000262613.5
NHERF1ENST00000413388.2 linkc.*420C>T 3_prime_UTR_variant Exon 5 of 5 2 ENSP00000464982.1

Frequencies

GnomAD3 genomes
AF:
0.501
AC:
76188
AN:
152074
Hom.:
19336
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.477
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.520
Gnomad ASJ
AF:
0.497
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.435
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.526
Gnomad OTH
AF:
0.483
GnomAD4 exome
AF:
0.507
AC:
22990
AN:
45356
Hom.:
5939
Cov.:
0
AF XY:
0.505
AC XY:
11723
AN XY:
23198
show subpopulations
African (AFR)
AF:
0.467
AC:
438
AN:
938
American (AMR)
AF:
0.553
AC:
1743
AN:
3150
Ashkenazi Jewish (ASJ)
AF:
0.483
AC:
607
AN:
1258
East Asian (EAS)
AF:
0.312
AC:
499
AN:
1598
South Asian (SAS)
AF:
0.453
AC:
2494
AN:
5506
European-Finnish (FIN)
AF:
0.571
AC:
1337
AN:
2342
Middle Eastern (MID)
AF:
0.378
AC:
68
AN:
180
European-Non Finnish (NFE)
AF:
0.521
AC:
14517
AN:
27874
Other (OTH)
AF:
0.513
AC:
1287
AN:
2510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
533
1067
1600
2134
2667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.501
AC:
76290
AN:
152192
Hom.:
19384
Cov.:
33
AF XY:
0.502
AC XY:
37329
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.478
AC:
19827
AN:
41520
American (AMR)
AF:
0.521
AC:
7961
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.497
AC:
1723
AN:
3470
East Asian (EAS)
AF:
0.306
AC:
1584
AN:
5180
South Asian (SAS)
AF:
0.434
AC:
2088
AN:
4812
European-Finnish (FIN)
AF:
0.554
AC:
5869
AN:
10602
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.526
AC:
35786
AN:
67998
Other (OTH)
AF:
0.488
AC:
1030
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1986
3973
5959
7946
9932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.512
Hom.:
55911
Bravo
AF:
0.501
Asia WGS
AF:
0.381
AC:
1328
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.2
DANN
Benign
0.49
PhyloP100
-0.39
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7420; hg19: chr17-72765215; COSMIC: COSV52853213; COSMIC: COSV52853213; API